ArticleFrontiers in cardiovascular medicine2026
GLP-1 receptor agonists alleviate inflammatory responses and endothelial dysfunction in atherosclerosis by activating the Sema3A/NRP1 pathway.
Lin Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.